1.
Clin Case Rep
; 8(8): 1538-1543, 2020 Aug.
Article
in English
| MEDLINE
| ID: mdl-32884791
ABSTRACT
Primary malignant melanoma of the uterine cervix is a rare disease with poor prognosis and high recurrence rate. We used Rigvir® as adjuvant therapy for a stage IVA patient. Tolerability, overall and progression-free survival are good.